The Powell Perspective

Investors await East Side Games Group's year-end results to see if a costly Q3 investment in new titles will finally pay off and reverse recent losses.

Venture capital leaders and national security experts caution that drug pricing controls and regulatory hurdles could cede America's biomedical edge to rivals.

EntTelligence's new platform aims to solve cinema advertising's measurement problem, bringing data-driven accountability to the big screen's captive audience.

A personal health crisis led Rodale Institute's CEO to a powerful conclusion: the key to our health is buried right under our feet. His new book explains why.

Amid soaring prices and geopolitical turmoil, Australian firm Llyodstern launches Petro-Insight, an AI platform aiming to bring clarity to a volatile market.

With new funding from Innovation Endeavors and YC, Conduit aims to replace spreadsheets and manual chaos with an AI-powered platform for dock operations.

Modalic's autonomous swarm software gets 'awardable' status, signaling a major shift in how the Department of War rapidly acquires advanced AI.

A new platform uses AI to turn complex genetic and lifestyle data into an immediate, actionable cancer prevention plan, shifting the paradigm of care.

Amid tough markets, Turkcell landed a landmark $1B Shariah-compliant deal, oversubscribed by 2.4x, to fuel its 5G rollout as Türkiye's digital leap begins.

Canadian law firms are adopting AI faster than global peers to boost profits, creating a performance gap and raising complex new ethical questions.

As AI agents gain autonomy, Proofpoint's new platform integrates email and data security to govern who—and what—can access an organization's sensitive data.

Chinese automaker SOUEAST launches an aggressive expansion in Latin America, joining a wave of brands vying for dominance in a rapidly evolving market.

A massive investment in a key Montreal factory aims to modernize iconic brands, secure over 1,000 jobs, and strengthen Canada's domestic food supply chain.

The investment house posts 40% profit growth and reaffirms ambitious 2026 targets, leveraging AI and international capital in a rebounding market.

Ractigen's RAG-01 advances with NMPA approval, using RNA activation to fight bladder cancer by targeting a previously 'undruggable' gene.

A new federated data space enables vital sectors to share intelligence without sacrificing control, boosting resilience against modern threats.

The redesigned Takes app uses AI to turn sports news into daily games and social challenges, aiming to transform how the next generation of fans engages.

Summit's partnership with Signet Financial underscores a fierce M&A strategy, a unique model for advisor independence, and a powerful bet on AI technology.

As workplace harassment persists, a new wave of cinematic, story-driven compliance training aims to transform corporate culture by making learning engaging.

Artelo Biosciences is testing a novel cannabinoid drug for glaucoma, aiming to protect vision in a way current treatments can't—all without diluting shares.